Related references
Note: Only part of the references are listed.Therapeutic targeting of TEAD transcription factors in cancer
Ajaybabu V. Pobbati et al.
TRENDS IN BIOCHEMICAL SCIENCES (2023)
Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration
Maria Camila Fetiva et al.
NUCLEIC ACIDS RESEARCH (2023)
A YAP/TAZ-CD54 axis is required for CXCR2-CD44- tumor-specific neutrophils to suppress gastric cancer
Pingping Nie et al.
PROTEIN & CELL (2023)
YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth
Xu Li et al.
EMBO JOURNAL (2023)
YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma
Thomas C. Frost et al.
JOURNAL OF CLINICAL INVESTIGATION (2023)
Context-dependent transcriptional regulations of YAP/TAZ in cancer
Yibo Guo et al.
CANCER LETTERS (2022)
YAP1 and PRDM14 converge to promote cell survival and tumorigenesis
Miju Kim et al.
DEVELOPMENTAL CELL (2022)
The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises
Angel Ortega et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
YAP/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis
Hongde Li et al.
NATURE CELL BIOLOGY (2022)
Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation
Juan Luo et al.
STEM CELL RESEARCH & THERAPY (2022)
YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
Xu Li et al.
NATURE COMMUNICATIONS (2022)
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
Shenghong Ma et al.
NATURE COMMUNICATIONS (2022)
Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers
Mengxin Luo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
YAP-VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP
Jing Cai et al.
GENES & DEVELOPMENT (2022)
YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers
Federica Lo Sardo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2022)
Hippo signaling instructs ectopic but not normal organ growth
W. Kowalczyk et al.
SCIENCE (2022)
YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis
Bo-Kuan Wu et al.
NATURE GENETICS (2022)
Roles of YAP/TAZ in ferroptosis
Suchitra Magesh et al.
TRENDS IN CELL BIOLOGY (2022)
PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer
Rama Krishna Nimmakayala et al.
CELL DEATH & DISEASE (2022)
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
Xu Li et al.
CELL DISCOVERY (2022)
A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth
Yu Ting Ong et al.
NATURE METABOLISM (2022)
YAP and TAZ Are Not Identical Twins
Francesca Reggiani et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
Ievgenia Pastushenko et al.
NATURE (2021)
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
Federica Lo Sardo et al.
CANCER LETTERS (2021)
Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation
Man Yu et al.
MOLECULAR CELL (2021)
STAT3-YAP/TAZ signaling in endothelial cells promotes tumor angiogenesis
Ying Shen et al.
SCIENCE SIGNALING (2021)
WWTR1(TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis
Caleb N. Seavey et al.
GENES & DEVELOPMENT (2021)
WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma
Jordan H. Driskill et al.
GENES & DEVELOPMENT (2021)
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma
Tracy T. Tang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
Nicole Merritt et al.
ELIFE (2021)
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity
Joel D. Pearson et al.
CANCER CELL (2021)
YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation
Lizhi He et al.
ELIFE (2021)
Mechanisms of YAP/TAZ transcriptional control
Giusy Battilana et al.
CELL STRESS (2021)
A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer
Wen-Hsuan Yang et al.
MOLECULAR CANCER RESEARCH (2020)
Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth
Ja Hyun Koo et al.
GENES & DEVELOPMENT (2020)
Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer
Chenxi Zhao et al.
ACTA PHARMACEUTICA SINICA B (2020)
YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators
Sany Hoxha et al.
CANCER RESEARCH (2020)
Yap suppresses T-cell function and infiltration in the tumor microenvironment
Eleni Stampouloglou et al.
PLOS BIOLOGY (2020)
Phase separation of TAZ compartmentalizes the transcription machinery to promote gene expression
Yi Lu et al.
NATURE CELL BIOLOGY (2020)
YAP/TAZ phase separation for transcription
J. Matthew Franklin et al.
NATURE CELL BIOLOGY (2020)
Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
Wenjie Yang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer
Nora Feldker et al.
EMBO JOURNAL (2020)
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer
Ying Shen et al.
CANCER CELL (2020)
Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer
Priscilla Cheung et al.
CELL STEM CELL (2020)
A Regulation Loop between YAP and NR4A1 Balances Cell Proliferation and Apoptosis
Lingli He et al.
CELL REPORTS (2020)
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Ajaybabu Pobbati et al.
THERANOSTICS (2020)
YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells
Shannon M. White et al.
DEVELOPMENTAL CELL (2019)
New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
Michal Shreberk-Shaked et al.
MOLECULAR ONCOLOGY (2019)
A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer
Chi Zhu et al.
MOLECULAR CELL (2019)
Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling
Jiao Wu et al.
NATURE (2019)
The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
Wen-Hsuan Yang et al.
CELL REPORTS (2019)
Targeting Oncogenic BRAF: Past, Present, and Future
Aubhishek Zaman et al.
CANCERS (2019)
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
Ivan M. Moya et al.
SCIENCE (2019)
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
Sarah A. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cell type-dependent function of LATS1/2 in cancer cell growth
Wei-Wei Pan et al.
ONCOGENE (2019)
Phase separation of YAP reorganizes genome topology for long-term YAP target gene expression
Danfeng Cai et al.
NATURE CELL BIOLOGY (2019)
TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC
Stacy Grieve et al.
BLOOD ADVANCES (2019)
A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Shumei Song et al.
MOLECULAR CANCER THERAPEUTICS (2018)
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
Helena J. Janse van Rensburg et al.
CANCER RESEARCH (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells
Chih-Sheng Yang et al.
EMBO REPORTS (2018)
PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin beta 2 expression
Huan Liu et al.
EMBO REPORTS (2018)
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
T. Azad et al.
NATURE COMMUNICATIONS (2018)
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
Daniel Martin et al.
NATURE COMMUNICATIONS (2018)
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
Xuhao Ni et al.
CANCER DISCOVERY (2018)
Interplay between YAP/TAZ and Metabolism
Ja Hyun Koo et al.
CELL METABOLISM (2018)
Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress
Xiaodong Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Francesca Zanconato et al.
NATURE MEDICINE (2018)
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
Dana Elster et al.
NATURE COMMUNICATIONS (2018)
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Zhiqiang Li et al.
CANCER CELL (2018)
Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer
Courtney M. Schaal et al.
MOLECULAR CANCER (2018)
Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology
Ameer L. Elaimy et al.
SCIENCE SIGNALING (2018)
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang et al.
CELL REPORTS (2018)
Single tumor-initiating cells evade immune clearance by recruiting type II macrophages
Xiaocan Guo et al.
GENES & DEVELOPMENT (2017)
YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
Wei Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Yan-Jiun Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Hippo pathway mediates resistance to cytotoxic drugs
Taranjit S. Gujral et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ
Deanna N. Edwards et al.
SCIENCE SIGNALING (2017)
YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis
Yiting Qiao et al.
CELL REPORTS (2017)
The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ
Deanna N. Edwards et al.
SCIENCE SIGNALING (2017)
VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
Yinglong Zhang et al.
SCIENTIFIC REPORTS (2017)
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma
Erika Cosset et al.
CANCER CELL (2017)
YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63-GPX2 Axis and ROS Accumulation
Hsinyi Huang et al.
CANCER RESEARCH (2017)
YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis
Xiaohong Wang et al.
DEVELOPMENTAL CELL (2017)
Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
Min Hwan Kim et al.
EMBO JOURNAL (2016)
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Guocan Wang et al.
CANCER DISCOVERY (2016)
The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity
Toshiro Moroishi et al.
CELL (2016)
Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
PuiYee Chan et al.
NATURE CHEMICAL BIOLOGY (2016)
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
Fuqin Fan et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling
Cameron L. Noland et al.
STRUCTURE (2016)
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Waltraut Lehmann et al.
NATURE COMMUNICATIONS (2016)
Tead and AP1 Coordinate Transcription and Motility
Xiangfan Liu et al.
CELL REPORTS (2016)
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
Willy Hugo et al.
CELL (2015)
YAP activates the Hippo pathway in a negative feedback loop
Xiaoming Dai et al.
CELL RESEARCH (2015)
The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer
Shumei Song et al.
CLINICAL CANCER RESEARCH (2015)
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
Toshiro Moroishi et al.
GENES & DEVELOPMENT (2015)
A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells
Cheng Chang et al.
GENES & DEVELOPMENT (2015)
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability
Hsuan-Yu Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers
Giorgio G. Galli et al.
MOLECULAR CELL (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness
Tackhoon Kim et al.
NATURE COMMUNICATIONS (2015)
Transcriptional Co-repressor Function of the Hippo Pathway Transducers YAP and TAZ
Minchul Kim et al.
CELL REPORTS (2015)
Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
Yusuke Oku et al.
FEBS OPEN BIO (2015)
Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Biao Ma et al.
NATURE CELL BIOLOGY (2015)
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
M. Bartucci et al.
ONCOGENE (2015)
Colorectal cancer statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
Fa-Xing Yu et al.
CANCER CELL (2014)
Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
Xiaodong Feng et al.
CANCER CELL (2014)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties
Shumei Song et al.
CANCER RESEARCH (2014)
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
Wenjing Zhang et al.
CELL RESEARCH (2014)
Identification of genomic alterations in oesophageal squamous cell cancer
Yongmei Song et al.
NATURE (2014)
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini et al.
NATURE MEDICINE (2014)
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Christopher T. Hensley et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Restriction of intestinal stem cell expansion and the regenerative response by YAP
Evan R. Barry et al.
NATURE (2013)
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
Fernando Calvo et al.
NATURE CELL BIOLOGY (2013)
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
Luc G. T. Morris et al.
NATURE GENETICS (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Transduction of mechanical and cytoskeletal cues by YAP and TAZ
Georg Halder et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation
Ian Lian et al.
GENES & DEVELOPMENT (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Mutations in GNA11 in Uveal Melanoma.
Catherine D. Van Raamsdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation
Africa Fernandez-L et al.
GENES & DEVELOPMENT (2009)
TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
Siew Wee Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition
Heng Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells
M. Zagurovskaya et al.
ONCOGENE (2009)
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells
Siew Wee Chan et al.
CANCER RESEARCH (2008)
Yes-associated protein (YAP) functions as a tumor suppressor in breast
M. Yuan et al.
CELL DEATH AND DIFFERENTIATION (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Yap1 phosphorylation by c-AbI is a critical step in selective activation of proapoptotic genes in response to DNA damage
Dan Levy et al.
MOLECULAR CELL (2008)
PML, YAP, and p73 Are Components of a Proapoptotic Autoregulatory Feedback Loop
Eleonora Lapi et al.
MOLECULAR CELL (2008)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
YAP1 increases organ size and expands undifferentiated progenitor cells
Fernando D. Camargo et al.
CURRENT BIOLOGY (2007)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
RASSRA elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the P73 tumor suppressor protein
David Matallanas et al.
MOLECULAR CELL (2007)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage
S Strano et al.
MOLECULAR CELL (2005)
The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis
KF Harvey et al.
CELL (2003)
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts
S Wu et al.
CELL (2003)
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
S Basu et al.
MOLECULAR CELL (2003)
Share Paper
